DCGI allows PNB Vesper Life Science to conduct phase-III clinical trials on PNB 001/GPP-BALACOVIN to… EP News Bureau Jun 24, 2021 PNB 001/GPP-BALACOVIN proving to be a major breakthrough in COVID-19 treatment
